Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis
- DOI
- 10.1186/s12933-022-01532-6
- Published
- 2022-06-15
- Container
- Cardiovascular Diabetology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12933-022-01532-6,
title = {Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis},
author = {Rongjun Zou and Wanting Shi and Junxiong Qiu and Na Zhou and Na Du and Hao Zhou and Xinxin Chen and Li Ma},
year = {2022},
journal = {Cardiovascular Diabetology},
doi = {10.1186/s12933-022-01532-6},
url = {https://doi.org/10.1186/s12933-022-01532-6}
}RIS
TY - JOUR TI - Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis AU - Rongjun Zou AU - Wanting Shi AU - Junxiong Qiu AU - Na Zhou AU - Na Du AU - Hao Zhou AU - Xinxin Chen AU - Li Ma PY - 2022 JO - Cardiovascular Diabetology DO - 10.1186/s12933-022-01532-6 UR - https://doi.org/10.1186/s12933-022-01532-6 ER -
APA
Zou, R., Shi, W., Qiu, J., Zhou, N., Du, N., Zhou, H., Chen, X., & Ma, L. (2022). Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-022-01532-6
Source records
- crossref · retrieved 2026-09-27T07:33:40.242Z